Comprehensive Financial Consultants Institutional, Inc. Pharma Cyte Biotech, Inc. Transaction History

Comprehensive Financial Consultants Institutional, Inc.

  • $231 Million
  • Q1 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 11, 2022
SELL
$1.91 - $2.77 $26 - $38
-14 Closed
0 $0
Q4 2021

Mar 10, 2022
BUY
$2.4 - $3.19 $33 - $44
14 New
14 $0

Others Institutions Holding PMCB

# of Institutions
32
Shares Held
1.07M
Call Options Held
5.4K
Put Options Held
400
View Full List

About PharmaCyte Biotech, Inc.

PMCB Quotes by TradingView
  • Ticker PMCB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,750,100
  • Market Cap $42.7M
  • Description
  • PharmaCyte Biotech, Inc., a biotechnology company, focuses on developing and commercializing cellular therapies for cancer, diabetes, and malignant ascites in the United States. Its cellular therapies are developed based on Cell-in-a-Box, a proprietary cellulose-based live cell encapsulation technology used as a platform to treat various types o...
More about PMCB
Track This Portfolio

Track Comprehensive Financial Consultants Institutional, Inc. Portfolio

Follow Comprehensive Financial Consultants Institutional, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Comprehensive Financial Consultants Institutional, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Comprehensive Financial Consultants Institutional, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email